Molecule intelOpportunity: Moderate0Crowded market

Flurbiprofen

158 brands · 133 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
37
Market saturation
100
Price room
100
Regulatory risk
50
158
brands
133
companies
Rs 166.3
median price
24
price points
5.45x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 82.54
MedianRs 166.3
Most expensiveRs 450
Spread5.45×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 5.45x across 24 trusted points (Rs 82.54-450.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Flurbiprofen — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2021-10-26
Drug Product Recall: Biofen Suspension (Batch # SP-67) by M/S. Bio-Labs Private Limited, I

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

133 canonical companies and 158 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 5.45x across 24 trusted points (Rs 82.54-450.0). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2021-10-26 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.